Passionate about IP! Since June 2003 the IPKat has covered copyright, patent, trade mark, designs, info-tech and confidentiality issues from a mainly UK and European perspective. Read, post comments and participate!

The team is Eleonora Rosati, Annsley Merelle Ward and Merpel. E-mail the Kats here!

The team is joined by GuestKats Söğüt Atilla, Oliver Fairhurst, Claire Gregg, Georgia Jenkins and Marcel Pemsel.

SpecialKats: Verónica Rodríguez Arguijo (TechieKat), Rose Hughes (PatKat) and Jocelyn Bosse (Book Review Editor).

InternKats: Wissam Bentazar, Simone Lorenzi and Kliment Markov.
Results for supplementary protection certificates
Veterinary versus human use under Article 3(d): CJEU asked to revisit Santen Veterinary versus human use under Article 3(d): CJEU asked to revisit Santen Reviewed by Dr Rose Hughes on Saturday, January 17, 2026 Rating: 5
[Guest Post] UK SPCs: Clinging to nurse, or fear of something worse? (Merck v Comptroller [2025] EWCA Civ 45) [Guest Post] UK SPCs: Clinging to nurse, or fear of something worse? (Merck v Comptroller [2025] EWCA Civ 45) Reviewed by Dr Rose Hughes on Wednesday, February 26, 2025 Rating: 5
UK takes uncompromising approach to interpretation of "the product" under Art. 3(a) SPC Regulation (Newron v Comptroller [2023] EWHC 1471) UK takes uncompromising approach to interpretation of "the product" under Art. 3(a) SPC Regulation (Newron v Comptroller [2023] EWHC 1471) Reviewed by Dr Rose Hughes on Monday, September 04, 2023 Rating: 5
Transitional provisions for the Windsor Framework: Is Northern Ireland "a new Liechtenstein" for SPCs? Transitional provisions for the Windsor Framework: Is Northern Ireland "a new Liechtenstein" for SPCs? Reviewed by Dr Rose Hughes on Monday, July 03, 2023 Rating: 5
What does the Windsor Framework mean for UK SPCs? What does the Windsor Framework mean for UK SPCs? Reviewed by Dr Rose Hughes on Tuesday, March 07, 2023 Rating: 5
Sweden gets into the Article 3 SPC referral game in AstraZeneca dapagliflozin case Sweden gets into the Article 3 SPC referral game in AstraZeneca dapagliflozin case Reviewed by Henry P Yang on Wednesday, March 01, 2023 Rating: 5
A new study on the options for a unified supplementary protection certificates (SPCs) system in Europe! A new study on the options for a unified supplementary protection certificates (SPCs) system in Europe! Reviewed by Frantzeska Papadopoulou on Monday, October 24, 2022 Rating: 5
European Commission consultation on unitary supplementary protection certificates (SPCs) European Commission consultation on unitary supplementary protection certificates (SPCs) Reviewed by Dr Rose Hughes on Thursday, March 24, 2022 Rating: 5
New SPC referral to the CJEU on the interpretation of Art 3(a) and (c) for combination products (Merck v Clonmel) New SPC referral to the CJEU on the interpretation of Art 3(a) and (c) for combination products (Merck v Clonmel) Reviewed by Dr Rose Hughes on Monday, March 07, 2022 Rating: 5
Subscribe to: Posts ( Atom )
Powered by Blogger.